RE: News outCardiac risk lowered:
https://www.cbc.ca/health/story/2007/12/27/triglyceride-study.html?ref=rss
Does not alter cholesterol level, sugar.
Basically, abnormality in fat distribution and inherent health risk related to that is being countered effectively and safely by tesamorelin.
This add value to molecule and opens new doors for anti-fat as 2nd indication.
General market isn't doing well, affects all stocks.
Scientific community praise is the first step, then commercial evaluation, then take-over price.
Story will not unfold in 1 week but in several times.
Press release is short. Wish I had access to data. Wait for analysts comments.
It's all good.
Maybe at later point more data on all cardiac markers.